ArticleTremor and other hyperkinetic movements (New York, N.Y.)2026
An Exploratory Analysis of Essential Tremor and Associated Phenotypes.
Article in Tremor and other hyperkinetic movements (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Essential Tremor (ET) is a highly heterogeneous movement disorder with a strong genetic basis. However, the etiology of ET is unclear, largely due to its clinical heterogeneity and frequently observed comorbidities. We conducted a three-part study to investigate the genetic basis of ET in relation to co-occurring phenotypes, aiming to assess causal directionality and to clarify phenotypic heterogeneity. First, we used Mendelian Randomization (MR) to test for directional, causal relationships between ET and common co-occurring traits. We then identified pleiotropic single nucleotide polymorphisms (SNPs) shared between ET and these traits, mapped them to genes, and performed gene ontology enrichment analyses. Finally, we applied genomic structural equation modeling (g-SEM) to group traits by shared genetic variance and evaluate their influence on ET. MR analyses did not reveal causal relationships, likely due to high genetic pleiotropy. Gene enrichment analyses of shared SNPs suggested involvement of certain pathways, but these signals were driven by limited gene overlap. SEM identified a well-fitting latent model of shared genetic architecture, but it explained only ~2% (±9%) of ET variance. Our findings suggest that ET and its comorbidities may share complex genetic architecture not captured by common variants alone. The limited variance explained by MR and SEM highlights the need for rare variant and multi-omics studies to better understand the biological mechanisms underlying ET and its heterogeneity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.